Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatWoundWistarMalen = 6 per group, 4 groups per phase, 24 rats per phase, 48 rats…Topical ointment; intraperitoneal injection for the arginine injection arm; transcutaneous laserArginine ointment 2 percent or 5 percent, approximately 0.0…Photobiomodulation started immediately after surgery; arginine started after wo…
Model: Single 15 mm full-thickness round excisional skin wound including the skin muscle on the proximal back, under ketamine 50 mg/kg and xylazine 5 mg/kg intramuscular anaesthesia
Arginine 2 percent was the most effective single arginine regimen for wound area reduction (p=0.000 versus arginine 5 percent, arginine injection and control). Photobiomodulation alone and photobiomodulation plus arginine 2 percent significantly improved wound strength and nearly all stereological…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.